Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01863693
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)

Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 300
Testing effectiveness (Phase 2)UnknownNCT04442984
What this trial is testing

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

Who this might be right for
Gastric Carcinoma Stage IVEsophagogastric Junction Adenocarcinoma Stage IV
Blokhin's Russian Cancer Research Center 326
Not applicableUnknownNCT05233358
What this trial is testing

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Who this might be right for
Hepatocellular Carcinoma
The Central Hospital of Lishui City 176
Testing effectiveness (Phase 2)UnknownNCT05179317
What this trial is testing

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Qilu Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT05262335
What this trial is testing

Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001)

Who this might be right for
Gastrointestinal Tumors
Ruijin Hospital 116
Large-scale testing (Phase 3)Study completedNCT02039726
What this trial is testing

(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive

Who this might be right for
AML
Daiichi Sankyo 367
Large-scale testing (Phase 3)UnknownNCT00021281
What this trial is testing

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05214222
What this trial is testing

Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Advanced Esophageal Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06245356
What this trial is testing

Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer

Who this might be right for
Metastatic Colorectal CancerMetastatic Gastroesophageal AdenocarcinomaDPD Deficiency
UNICANCER 73
Large-scale testing (Phase 3)Looking for participantsNCT07777822
What this trial is testing

Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC

Who this might be right for
NSCLCNon-small Cell Lung CancerNon-Small Cell Lung Cancer NSCLC+4 more
Revolution Medicines, Inc. 430
Testing effectiveness (Phase 2)Study completedNCT00402051
What this trial is testing

Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small-Cell Lung Cancer
Eli Lilly and Company 133
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07637851
What this trial is testing

Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 43
Testing effectiveness (Phase 2)UnknownNCT04692051
What this trial is testing

A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Huazhong University of Science and Technology 100
Early research (Phase 1)UnknownNCT06356701
What this trial is testing

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

Who this might be right for
Long-Term Effects Secondary to Cancer Therapy
The First Affiliated Hospital of Dalian Medical University 120
Large-scale testing (Phase 3)WithdrawnNCT04806945
What this trial is testing

A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Shanghai Henlius Biotech
Large-scale testing (Phase 3)UnknownNCT04951648
What this trial is testing

A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 220
Not applicableStudy completedNCT02305615
What this trial is testing

An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC)

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 300
Testing effectiveness (Phase 2)Study completedNCT00590447
What this trial is testing

Risk Stratified Sequential Treatment for CD20-positive PTLD

Who this might be right for
PTLDPosttransplant Lymphoproliferative Disorder
Charite University, Berlin, Germany 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07622550
What this trial is testing

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00129727
What this trial is testing

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

Who this might be right for
Ovarian Cancer
Massachusetts General Hospital 62
Next Page